Review decision: 

This guideline will shortly be checked to see if it needs updating, please register as a stakeholder to be informed about the decision.

Register as a stakeholder

Next review date: March 2016

This guideline offers evidence-based advice on the care and treatment of people with lung cancer. New and updated recommendations are included on communication, diagnosis and staging, selection of patients with non-small-cell lung cancer (NSCLC) for treatment with curative intent, surgery with curative intent for NSCLC, smoking cessation, combination treatment for NSCLC, treatment for small-cell lung cancer (SCLC), managing endobronchial obstruction, managing brain metastases, and follow-up and patient perspectives.

This guideline was previously called lung cancer: the diagnosis and treatment of lung cancer.

Recommendations 1.1.2 to 1.1.5 have been replaced by NICE guideline NG12 (published June 2015).

This guidance updates and replaces NICE guideline CG24 (published February 2005).

  • National Institute for Health and Care Excellence (NICE) accreditation logo